RAD001 also enhanced P-ERK1/2 levels in SKBR3 and MCF7-HER2 cells and in JIMT-1 tumors and these results are in agreement with studies showing activation of ERK1/2 through a PI3K-dependent feedback loop following inhibition of mTORC1 in some human cancers [57]. Here, MAPK3 is linked to cancer.